Gyre Therapeutics (GYRE) Tax Rate (2010 - 2026)
Gyre Therapeutics (GYRE) posted quarterly Tax Rate of 6.72% for Q1 2026, down 2616.0% year-over-year from 0.27% in Q1 2025, and down 101.98% quarter-over-quarter from 339.39% in Q4 2025.
Gyre Therapeutics (GYRE) Tax Rate (2010 - 2026) Analysis & Trends
Gyre Therapeutics (GYRE) has reported Tax Rate for 8 consecutive years, with 6.72% the latest figure, recorded in Q1 2026.
- In Q1 2026, Tax Rate fell 2616.0% year-over-year to 6.72%; the TTM figure through Mar 2026 stood at 487.94% (up 46404.0% YoY), while the FY2025 annual figure was 21.0%, down 191.0% from the prior year.
- Tax Rate retreated to 6.72% in Q1 2026 per GYRE's latest filing, from 339.39% in the prior quarter.
- Across five years, Tax Rate topped out at 339.39% in Q4 2025 and bottomed at 26.26% in Q4 2022.
- Historically, Tax Rate has averaged 41.21% across 5 years, with a median of 25.55% in 2024.
- Annual changes were most pronounced in 2025 — Tax Rate soared 31310 bps — and 2026, when it sank 2616 bps.
- Gyre Therapeutics' Tax Rate stood at 26.26% in 2022, then surged by 97 bps to 0.7% in 2023, then surged by 3872 bps to 26.3% in 2024, then surged by 1191 bps to 339.39% in 2025, then slumped by 102 bps to 6.72% in 2026.
- Business Quant data shows GYRE's Tax Rate at 6.72% in Q1 2026, 339.39% in Q4 2025, and 22.19% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.91% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 24.15% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9.47% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 7.49% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.71% |
| 10 | Gyre Therapeutics | 708.31 Mn | 685.47 Mn | 26.90 Mn | 1.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.14% |
| Jun 30, 2026 | 1.14% |
| Jun 30, 2026 | 1.14% |
| Mar 31, 2026 | -6.72% |
| Mar 31, 2026 | -6.72% |
| Mar 31, 2026 | -6.72% |
| Dec 31, 2025 | 339.39% |
| Dec 31, 2025 | 339.39% |
| Dec 31, 2025 | 339.39% |
| Sep 30, 2025 | 22.19% |
| Sep 30, 2025 | 22.19% |
| Sep 30, 2025 | 22.19% |
| Jun 30, 2025 | 29.58% |
| Jun 30, 2025 | 29.58% |
| Jun 30, 2025 | 29.58% |
| Mar 31, 2025 | 19.44% |
| Mar 31, 2025 | 19.44% |
| Mar 31, 2025 | 19.44% |
| Dec 31, 2024 | 26.30% |
| Dec 31, 2024 | 26.30% |